Literature DB >> 10526031

Accuracy of endorectal ultrasound after preoperative radiochemotherapy in locally advanced rectal cancer.

B Rau1, M Hünerbein, C Barth, P Wust, W Haensch, H Riess, R Felix, P M Schlag.   

Abstract

OBJECTIVES: Factors limiting the accuracy of endorectal ultrasound in staging, locally advanced primary rectal cancer after preoperative neoadjuvant radiochemotherapy (RCT) were evaluated.
METHODS: Patients (n = 84) with initial locally advanced rectal cancer (uT3/uT4) undergoing R0 resection were investigated after preoperative treatment that combined radiotherapy up to 45 Gy with two cycles of chemotherapy (5-FU and leucovorin on d 1-5 and 22-28). At 4 to 6 weeks after completion of RCT and before tumor resection, preoperative endoluminal ultrasound was performed.
RESULTS: The accuracy to predict the depth of tumor infiltration (T-category) was found to correlate with downstaging. The T-category was correctly staged before surgery in 15 of the 51 responders (29%) and in 27 of 33 nonresponders (82%), whereas misinterpretation occurred in 36 of the responders (71%) and in 6 of the nonresponders (18%) (p < 0.001). Neither tumor distance from anal verge nor tumor location correlated with the staging accuracy. Lymph node involvement was correctly assessed in 48 patients (57%). Wall invasion was correctly ascertained in 42 patients (50%), with under estimation in 11 patients (13%) and overestimation in 31 patients (37%).
CONCLUSIONS: After radiochemotherapy, endosonography does not provide a satisfactory accuracy for preoperative staging of rectal cancer. New interpretation and diagnostic criteria are needed for the prediction of treatment response.

Entities:  

Mesh:

Year:  1999        PMID: 10526031     DOI: 10.1007/s004649901151

Source DB:  PubMed          Journal:  Surg Endosc        ISSN: 0930-2794            Impact factor:   4.584


  29 in total

1.  Positron emission tomography with [(18)F]-3'-deoxy-3'fluorothymidine (FLT) as a predictor of outcome in patients with locally advanced resectable rectal cancer: a pilot study.

Authors:  Farrokh Dehdashti; Perry W Grigsby; Robert J Myerson; Ilke Nalbantoglu; Changqing Ma; Barry A Siegel
Journal:  Mol Imaging Biol       Date:  2013-02       Impact factor: 3.488

2.  Accuracy of endorectal ultrasonography in staging locally advanced rectal cancer after preoperative chemoradiation.

Authors:  Zoran Radovanovic; M Breberina; T Petrovic; A Golubovic; D Radovanovic
Journal:  Surg Endosc       Date:  2008-07-12       Impact factor: 4.584

3.  Endorectal ultrasound: its role in the diagnosis and treatment of rectal cancer.

Authors:  Bret R Edelman; Martin R Weiser
Journal:  Clin Colon Rectal Surg       Date:  2008-08

Review 4.  How Should Imaging Direct/Orient Management of Rectal Cancer?

Authors:  Jemma Bhoday; Svetlana Balyasnikova; Anita Wale; Gina Brown
Journal:  Clin Colon Rectal Surg       Date:  2017-11-27

Review 5.  Multimodal imaging evaluation in staging of rectal cancer.

Authors:  Suk Hee Heo; Jin Woong Kim; Sang Soo Shin; Yong Yeon Jeong; Heoung-Keun Kang
Journal:  World J Gastroenterol       Date:  2014-04-21       Impact factor: 5.742

6.  ¹⁸F-FDG PET/CT-based treatment response evaluation in locally advanced rectal cancer: a prospective validation of long-term outcomes.

Authors:  Felipe A Calvo; Claudio V Sole; Dolores de la Mata; Luis Cabezón; Marina Gómez-Espí; Emilio Alvarez; Paz Madariaga; José L Carreras
Journal:  Eur J Nucl Med Mol Imaging       Date:  2013-02-23       Impact factor: 9.236

Review 7.  Magnetic resonance imaging in rectal cancer: a surgeon's perspective.

Authors:  Avanish P Saklani; Sung Uk Bae; Amy Clayton; Nam Kyu Kim
Journal:  World J Gastroenterol       Date:  2014-02-28       Impact factor: 5.742

8.  Role of three-dimensional anorectal ultrasonography in the assessment of rectal cancer after neoadjuvant radiochemotherapy: preliminary results.

Authors:  Sthela M Murad-Regadas; Francisco Sergio P Regadas; Lusmar V Rodrigues; Rosilma G L Barreto; Francisco Coracy C Monteiro; Beethoven B Landim; Erico C Holanda
Journal:  Surg Endosc       Date:  2008-09-24       Impact factor: 4.584

9.  Instrumental clinical restaging, pathological evaluation, and tumor regression grading: how to assess the response to neoadjuvant chemoradiotherapy for rectal cancer.

Authors:  Enrico Benzoni; Giovanni Terrosu; Donatella Intersimone; Elisa Milan; Germana Chiaulon; Vittorio Bresadola; Cosimo Sacco; Elisa Sattin; Fabrizio Bresadola; Claudio Avellini
Journal:  Int J Colorectal Dis       Date:  2006-03-15       Impact factor: 2.571

Review 10.  Multidisciplinary treatment of rectal cancer in 2014: where are we going?

Authors:  Andrea Vignali; Paola De Nardi
Journal:  World J Gastroenterol       Date:  2014-08-28       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.